Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ASN 001

Drug Profile

ASN 001

Alternative Names: ASN001

Latest Information Update: 30 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Asana BioSciences
  • Class Antineoplastics
  • Mechanism of Action Steroid 17-alpha-hydroxylase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Prostate cancer

Most Recent Events

  • 07 Mar 2018 Asana BioSciences terminates a phase-I/II trial in Prostate cancer (Hormone refractory, Metastatic disease) in USA due to a business decision (NCT02349139)
  • 05 Sep 2017 Phase-I/II development is ongoing for Prostate cancer (Hormone refractory, Metastatic disease) in USA (NCT02349139)
  • 02 Jun 2017 Efficacy, adverse events, pharmacokinetics and pharmacodynamics data from a phase I/II trial in Prostate cancer presented at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO-2017)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top